Deep neck abscesses (DNA) are one of the most frequent surgical emergencies in the otolaryngology and head and neck surgery.1,2 The urgency in their treatment lies in avoiding complications and then reducing the morbidity and mortality derived from this.3,4 His principal complication is airway obstruction.4,5 In these cases, patients should receive Advance Airway Management (AAM) in addition to drain the abscess; however, it is difficult to predict which patients will require such management and which will not.6–9 In recent years, some factors have been identified in order to create scales or scores to stratify the risk of complications of DNA, some with excellent results, and others have been shown to be able to predict whose will require AAM.10–13

To validate the clinical usefulness of a clinical risk scale to predict the requirement of AAM in adult patients with a diagnosis of DNA.

A sample of 213 patients was obtained, 121 (56.8%) men, of whom 50 (23.5%) required AAM. The mean age was 52±16 years. Orotracheal intubation was used in 40 (80%) of the patients who required AAM and in the other 10 (20%) tracheostomy was used. (Table 1) The most frequent location of the collection was the suprahyoid region in 139 (65.3%) patients, of which 41 (29.4%) required AAM. Multiple space involvement was observed in 77% and was present in 98% of those requiring AAM (p=0.001). All those who required AAM had compromise of the retropharyngeal space (p=0.001). In a bivariate manner, (intubated or not) significant differences were found in the presence of dyspnea, multiple space involvement, presence of affected space corpuscles, and platelet/lymphocyte ratio (Table 1).

Using an ROC curve, the area under the estimated curve was 0.926 with a cut-off point of 0.451. With this new cut-off point, a sensitivity of 97.7% was obtained, and a specificity of 85.3% (Fig. 1). A sensitivity of 0.975 and a specificity of 0.659 (p=0.001, 95% CI 0.856–0.984) were found for the clinical risk scale. The median score obtained on the clinical scale for the group of patients who required AAM was 70.6% risk, while in the group of those who did not require AAM the median score was 4.2% risk, managing to increase specificity and the predictive value+with the new cut-off point proposed (Table 2).

Figure 1.

ROC (Receiver Operating Characteristic) Curve. The estimated Area Under the Curve (AUC) was 0.926 with a cut-off point of 0.451. With this new cut-off point, a sensitivity of 97.7% and a specificity of 85.3% was obtained.

(0.09MB).

A clinical scale was applied in patients with a diagnosis of deep neck abscess, to predict the risk of requiring AAM and thus validate its usefulness in our population.14 We found a predominance in the male gender, however, this was not significant (p=0.383). Regarding age, after 55 years the risk of requiring advanced airway management increases (p=0.05) similar to that reported in other studies, where the risk was higher after 60 years.14 Dyspnea was the most relevant clinical data, present in 2% of those who did not require AAM, against 98% of those who did, (p=0.001) consistent with other publications, where it was reported to occur in 6.6% of patients who do not require AAM (p<0.001).15

The formation of gas in infectious processes is associated with the presence of anaerobic bacteria, contributing to its spread, and is therefore considered a prognostic factor for airway management.15 Air corpuscles were present in 72% of those who required AAM, while only 28% of those did not (p=0.001). Other investigators have observed air corpuscles in up to 71.7% of those requiring AAM.15 The percentage of neutrophils in the blood and the platelet/lymphocyte ratio were found to be elevated in both groups (p=0.595 and 0.396 respectively). In some publications, lower values of these parameters have been found in those who did not require AAM,16,17 probably because the patients sought care in advanced stages of the disease, when both biomarkers were already very elevated, except in those with more severe infection, who presented increased ranges, making it possible to identify those with a higher risk of requiring AAM.17–20

In the context of an infectious disease, hypoalbuminemia is an indicator of metabolic stress, therefore, in DNA, it can serve as a marker of severity and prognosis of AAM.21–23 This variable was not significant (p=0.138) possibly because the patients had a very deteriorated metabolic state and significant comorbidities, unlike other authors who have reported hypoalbuminemia as a significant variable (p≤0.001) due to the better general conditions of their patients.23–25 One of the strengths of this study is that it was carried out in a single center, therefore, the reliability of the results is high, since all the patients were treated under similar conditions and following the same diagnostic-therapeutic protocol, in addition to being a reference hospital, the sample obtained was quite significant (213 patients in 7 years). However, as retrospective study, there may be selection bias as most patients are in more advanced stages of the disease.

The main benefit of this clinical risk scale is its implementation as a tool that will allow the timely identification of patients who may require advanced airway management, with a positive impact on their prognosis by reducing the mortality rate when performing intubation or tracheostomy. timely manner.

The clinical risk scale developed by Lin et al. in patients diagnosed with deep neck abscess may be applicable in the Mexican population.

This clinical risk scale can be implemented as an additional tool that, together with the knowledge and experience of medical personnel, will allow us to identify those patients more safely with a higher risk of requiring advanced airway management. Detecting these patients in a timely manner has a positive impact on their prognosis since the mortality rate can be reduced by carry out important actions such as notifying support staff (anesthesiology, nursing, inhalation therapy, etc.) and prepare all the equipment necessary to intubate or perform a tracheostomy.

None.

The authors declare no conflicts of interest.